Novo Halts Work on Cell Therapy Cure for Diabetes to Cut Costs
NegativeTechnology

Novo Nordisk has decided to halt its cell therapy division aimed at curing type 1 diabetes, a move that reflects the company's shift in focus towards more profitable areas like obesity and diabetes treatments. This decision is significant as it indicates a retreat from innovative approaches in diabetes care, potentially leaving many patients without hope for a groundbreaking cure.
— Curated by the World Pulse Now AI Editorial System